Henan Genuine Biotech Co., Ltd.

This study is testing a new two-drug combination (GEN-725 plus Dositinib) for people with advanced lung cancer that has a specific genetic change (EGFR mutation). It aims to see if the treatment is safe and if it can shrink tumors, including those that have spread to the brain. T…

This is the first study in people testing a new oral medication called GEN-725 for advanced solid tumors that have progressed after standard treatments. The main goals are to find a safe dose, see how the drug moves through the body, and check for any early signs that it might he…

This study is testing a new oral medication called Dositinib for adults with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation). The main goals are to find a safe and effective dose and to see how well the drug controls the cancer. The study is…

This study is testing a new oral medication called CL-197 for people with HIV who have never taken any HIV drugs before. The main goal is to see how well a single dose lowers the amount of virus in the blood and to check if it is safe. Researchers will also measure how the drug m…